Showing results (411-420 of 537) with videos related to

Sort By:
Pageof 54
Bone Marrow Transplantation|January 1, 1991
Allogeneic vs autologous BMT vs intensive chemotherapy in childhood AnLL during first complete remission: AIEOP experience. AIEOP Cooperative GroupW Arcese, S Amadori, A M Testi, et al.
Haematologica|March 21, 1998
A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University "La Sapienza" of RomeA M Testi, M L Moleti, F Giona, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA)S Keating, T de Witte, S Suciu, et al.
Lancet (London, England)|March 26, 1994
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study GroupH G Prentice, E Gluckman, R L Powles, et al.
Leukemia|January 1, 1991
Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patientsG Cimino, S Amadori, M C Cava, et al.
Haematologica|May 1, 1989
Intensification in post-remission treatment of adult acute non lymphocytic leukemiaM C Petti, M A Aloe Spiriti, A M Carella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2001
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropeniaA Del Favero, F Menichetti, P Martino, et al.
Haematologica|December 24, 1997
A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of RomeA M Testi, M L Moleti, F Giona, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
British Journal of Haematology|May 31, 2001
Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemiaM R Ricciardi, M T Petrucci, C Gregorj, et al.
Pageof 54